ID16781A - PHARMACEUTICAL FORMULATIONS - Google Patents
PHARMACEUTICAL FORMULATIONSInfo
- Publication number
- ID16781A ID16781A IDP970927A ID970927A ID16781A ID 16781 A ID16781 A ID 16781A ID P970927 A IDP970927 A ID P970927A ID 970927 A ID970927 A ID 970927A ID 16781 A ID16781 A ID 16781A
- Authority
- ID
- Indonesia
- Prior art keywords
- pharmaceutical formulations
- formulations
- pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1389396P | 1996-03-22 | 1996-03-22 | |
| GBGB9606372.2A GB9606372D0 (en) | 1996-03-26 | 1996-03-26 | Pharmaceutical formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID16781A true ID16781A (en) | 1997-11-13 |
Family
ID=26308992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDP970927A ID16781A (en) | 1996-03-22 | 1997-03-21 | PHARMACEUTICAL FORMULATIONS |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JP3117726B2 (en) |
| AR (1) | AR006345A1 (en) |
| BG (1) | BG64457B1 (en) |
| CO (1) | CO4790151A1 (en) |
| HU (1) | HU228026B1 (en) |
| ID (1) | ID16781A (en) |
| IL (1) | IL126185A (en) |
| MY (1) | MY126358A (en) |
| OA (1) | OA10880A (en) |
| PL (1) | PL187919B1 (en) |
| TW (1) | TW455491B (en) |
| WO (1) | WO1997035587A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2264718C (en) * | 1996-09-01 | 2006-05-30 | Pharmos Corporation | Solid coprecipitates for enhanced bioavailability of lipophilic substances |
| AU8145198A (en) * | 1997-06-16 | 1999-01-04 | Vertex Pharmaceuticals Incorporated | Methods of increasing the bioavailability of stable crystal polymorphs of a compound |
| US5891845A (en) * | 1997-11-21 | 1999-04-06 | Fuisz Technologies Ltd. | Drug delivery systems utilizing liquid crystal structures |
| ES2140329B1 (en) * | 1997-12-04 | 2000-10-16 | Univ Granada | USE OF MASLINIC ACID AS A PROTEASE INHIBITOR FOR THE TREATMENT OF DISEASE CAUSED BY THE VIRUSES OF ACQUIRED IMMUNODEFICIENCY. |
| GB9812189D0 (en) * | 1998-06-05 | 1998-08-05 | Glaxo Group Ltd | Methods and compositions for increasing penetration of HIV protease inhibitors |
| CA2432527A1 (en) * | 2000-12-22 | 2002-07-04 | Takeda Chemical Industries, Ltd. | Medicinal compositions for oral use |
| WO2004050068A1 (en) | 2002-11-29 | 2004-06-17 | Janssen Pharmaceutica N.V. | Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
| EP1592760A4 (en) | 2003-01-31 | 2009-08-12 | Smithkline Beecham Corp | Solid dispersion compositions |
| EP1799194B1 (en) * | 2004-09-24 | 2011-11-16 | Boehringer Ingelheim Pharmaceuticals Inc. | A new class of surfactant-like materials comprising vitamin e tpgs and a water soluble polymer |
| EP1793806A2 (en) * | 2004-09-30 | 2007-06-13 | Eastman Chemical Company | Pharmaceutical formulations containing vitamin e tpgs molecules that solubilize lipophilic drugs without significant efflux inhibition, and use of such formulations |
| EP1880715A1 (en) * | 2006-07-19 | 2008-01-23 | Abbott GmbH & Co. KG | Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same |
| SA109300195B1 (en) | 2008-03-28 | 2013-04-20 | Astrazeneca Ab | A Novel Anti-Cancer Pharmaceutical Composition |
| ITRM20120331A1 (en) | 2012-07-12 | 2014-01-13 | Guidotti & C Spa Labor | LIQUID ORAL PEDIATRIC COMPOSITIONS CONTAINING NEPADUTANT. |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992016501A1 (en) * | 1991-03-20 | 1992-10-01 | Vertex Pharmaceuticals Incorporated | Tetrahydroxyalkane derivatives as inhibitors of hiv aspartyl protease |
| NZ244986A (en) * | 1991-11-08 | 1995-10-26 | Merck & Co Inc | Hiv protease inhibitor and pharmaceutical compositions |
| IS2334B (en) * | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl protease inhibitor of a new class of sulfonamides |
| WO1994013629A1 (en) * | 1992-12-11 | 1994-06-23 | Vertex Pharmaceuticals Incorporated | Mannitol derivatives and their use as inhibitors of aspartyl protease |
| US5484926A (en) * | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| DE10199053I1 (en) * | 1992-12-29 | 2002-08-29 | Abbott Lab | Retroviral protease inhibitors |
| ATE179164T1 (en) * | 1993-01-15 | 1999-05-15 | Agouron Pharma | HIV PROTEASE INHIBITORS |
| WO1995012583A1 (en) * | 1993-11-05 | 1995-05-11 | Merck & Co., Inc. | New quinazolines as inhibitors of hiv reverse transcriptase |
| IL111584A0 (en) * | 1993-11-18 | 1995-01-24 | Merck & Co Inc | Prodrugs of an inhibitor of hiv protease and pharmaceutical compositions containing them |
| HUT74681A (en) * | 1993-12-15 | 1997-01-28 | Merck & Co Inc | N-(2-hydroxy-1-indenyl)-2-phenylmethyl-4-hydroxy-5-(2-carboxamido-piperazinyl)-pentaneamide derivatives of hiv protease inhibitor activity and phrmaceutical compositions contining them |
| WO1995024385A1 (en) * | 1994-03-07 | 1995-09-14 | Vertex Pharmaceuticals Incorporated | Sulphonamide derivatives as aspartyl protease inhibitors |
| GB9409778D0 (en) * | 1994-05-16 | 1994-07-06 | Dumex Ltd As | Compositions |
| US5527829A (en) * | 1994-05-23 | 1996-06-18 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| EP0825849A1 (en) * | 1995-05-19 | 1998-03-04 | Abbott Laboratories | Self-emulsifying formulations of lipophilic drugs |
-
1997
- 1997-03-20 MY MYPI97001186A patent/MY126358A/en unknown
- 1997-03-21 WO PCT/EP1997/001438 patent/WO1997035587A1/en active IP Right Grant
- 1997-03-21 AR ARP970101146A patent/AR006345A1/en active IP Right Grant
- 1997-03-21 TW TW086103607A patent/TW455491B/en not_active IP Right Cessation
- 1997-03-21 JP JP09534017A patent/JP3117726B2/en not_active Expired - Lifetime
- 1997-03-21 IL IL12618597A patent/IL126185A/en not_active IP Right Cessation
- 1997-03-21 CO CO97015457A patent/CO4790151A1/en unknown
- 1997-03-21 HU HU9901887A patent/HU228026B1/en unknown
- 1997-03-21 ID IDP970927A patent/ID16781A/en unknown
- 1997-03-21 PL PL32891697A patent/PL187919B1/en unknown
-
1998
- 1998-09-18 OA OA9800171A patent/OA10880A/en unknown
- 1998-10-12 BG BG102838A patent/BG64457B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BG102838A (en) | 1999-09-30 |
| JP3117726B2 (en) | 2000-12-18 |
| IL126185A0 (en) | 1999-05-09 |
| MY126358A (en) | 2006-09-29 |
| IL126185A (en) | 2003-05-29 |
| TW455491B (en) | 2001-09-21 |
| PL187919B1 (en) | 2004-11-30 |
| PL328916A1 (en) | 1999-03-01 |
| OA10880A (en) | 2001-10-11 |
| WO1997035587A1 (en) | 1997-10-02 |
| HUP9901887A2 (en) | 1999-12-28 |
| AR006345A1 (en) | 1999-08-25 |
| BG64457B1 (en) | 2005-03-31 |
| JP2000500504A (en) | 2000-01-18 |
| HU228026B1 (en) | 2012-08-28 |
| HUP9901887A3 (en) | 2000-02-28 |
| CO4790151A1 (en) | 1999-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9610153A (en) | Pharmaceutical formulations | |
| BR9611626A (en) | Pharmaceutical formulations | |
| ID23299A (en) | PHARMACEUTICAL FORMULATIONS | |
| ID24654A (en) | OMEPRAZOLA PHARMACEUTICAL FORMULATION | |
| ID18352A (en) | PHARMACEUTICAL COMPOSITIONS | |
| DE69530325D1 (en) | AEROSOL DRUG FORMULATIONS | |
| MA24473A1 (en) | FORMULATIONS | |
| FI20071025L (en) | Pharmaceutical compositions | |
| NO954486D0 (en) | Pharmaceutical formulation basis | |
| FI991302L (en) | Improved pharmaceutical compositions | |
| ID16781A (en) | PHARMACEUTICAL FORMULATIONS | |
| TR199501082A2 (en) | Pharmaceutical formulations. | |
| ID29294A (en) | PHARMACEUTICAL COMPOSITION | |
| ITMI941169A0 (en) | PHARMACEUTICAL FORMULATIONS | |
| PT941100E (en) | PHARMACEUTICAL COMPOSITIONS | |
| EE03511B1 (en) | Prolonged release pharmaceutical preparations containing misolastin | |
| ID25857A (en) | PHARMACEUTICAL COMPOSITION | |
| FI951155A7 (en) | Pharmaceutical preparation | |
| FI961364L (en) | Drug composition | |
| ITMI962628A0 (en) | PHARMACEUTICAL COMPOSITION | |
| NO991430L (en) | Insecticide formulations | |
| FI954050L (en) | Pharmaceutical compositions | |
| ID23531A (en) | PHARMACEUTICAL COMPOSITION | |
| SE9600141D0 (en) | Pharmaceutical formulation | |
| SE9404467D0 (en) | Drug formulations |